Case Study: Small Pharmaceutical Manufacturing Company achieves improved market access insights and streamlined operations with IntegriChain

Improving Market Access Insights and Operations through Vendor Consolidation

Small Pharmaceutical Manufacturing Company launched a complex IV-to-oral therapy in 2019 and struggled with fragmented market access operations: multiple vendors, poor channel and patient data quality, limited visibility into patient journey KPIs, slow contract/pricing support, and a gross-to-net process that wouldn’t scale. To address these gaps the company engaged IntegriChain, leveraging its ICyte Data Refinery and ICyte Platform capabilities to assess and redesign their market access and GTN processes.

IntegriChain consolidated the manufacturer’s vendors and implemented GP and Rebate Managed Services, GTN forecasts and accruals, patient data aggregation/mastering, Specialty Pharmacy Analytics, and advisory services. Using the ICyte Data Refinery for de‑identification, mastering and automated data quality checks, IntegriChain delivered audit-ready GTN forecasts, faster GTN close, improved forecast accuracy, longitudinal patient insights (Time to First Fill, First Fill Rates, Time on Therapy), and end-to-end visibility into dispensing and inventory — while enabling reduced market-access cost through operational consolidation.